All News

The FDA has granted rusfertide breakthrough therapy designation for patients with polycythemia vera, a step that could speed its path to approval.

Dr. Neal Patel says biopsy results may not fully capture prostate cancer risk, stressing that PSA, stage and disease volume should also guide treatment.

In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, female and non-White patients.

Creating our own metaphors to stand up to cancer can help with the healing journey; own words can give us a better sense of control.

DecisionDx-SCC may help doctors more accurately guide treatment in high-risk cutaneous squamous cell carcinoma, the second most common form of skin cancer.

A survivor shares how family, care teams and mentoring others helped her face stage 3C ovarian cancer and reclaim independence with hope.

An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers.

It is vital to acknowledge early symptoms, seek specialized care, as well as an expert opinion when it comes to gastrointestinal stromal tumor treatment.

The FDA’s accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation sets the stage for more treatment advancements.

Dena Champion, dietician, explains how taste/smell changes from cancer treatment can make eating difficult and affect recovery.

Breast cancer types, staging, diagnosis, treatment, and survivorship are complex, but understanding them helps patients make informed care decisions.

Early-stage kidney cancer is limited to the kidney, usually under seven centimeters and often has a very good prognosis when treated promptly.

This guide provides an overview of bladder cancer, from diagnosis to treatment, helping patients understand options, manage side effects, and plan care.

After my breast cancer diagnosis, blogging became a way to process emotions, share updates with loved ones, and connect with others facing similar journeys

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid tumors.

Alpha1H shows benefit in non-muscle invasive bladder cancer, shrinking tumors and boosting the immune system with manageable side effects.

Multiple myeloma is a chronic blood cancer affecting plasma cells, but with today’s treatments many patients can manage symptoms and live fulfilling lives.

In a defining moment for both my husband and me, we learned of the need for and the meaning of support during a cancer journey.

Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about why she remains hopeful for the future or cancer vaccines.

In an interview, Dr. Rosario Ligresti highlighted what patients with gastrointestinal stromal tumors, or GIST, should know upon starting treatment.

I share how my daughter’s cancer team let me stay involved and supported, helping me remain present as her mom through every step of treatment.

A structured nurse-led clinic can help patients with myeloproliferative neoplasms receive timely support, as well as bridge gaps in symptom reporting.

The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should be aware of.

CURE spoke with an expert about the needs of children in families living with cancer during back-to-school season.

When a family member receives a diagnosis, it can present emotional challenges for children.

Kimberly (Cary) Demirhan discusses the need for more diversity and inclusivity in clinical trials for patients with cancer.

The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form.

Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love by your side.